Abstract:Barriers to achieve sustained HIV virological suppression on antiretroviral therapy (ART) jeopardize the success of the 90:90:90 UNAIDS initiative which aims to end the HIV/AIDS epidemic. In France, where access to ART is free and universally available, we analyze the way in which social determinants of health (i.e. cultural, environmental) and economic factors might influence virological outcomes. A cross-sectional study was performed in two hospitals located in Paris area. All consecutive people living with … Show more
“…Detectable VL was more common among ART recipients in the United Kingdom with unstable housing, non-university education, unemployment and financial hardship [15]. Other social and structural factors, such as homelessness, injection drug use and lack of social support, have also been associated with viremia during ART [16,17].…”
Section: Discussionmentioning
confidence: 99%
“…Lack of virological suppression during ART has been associated with advanced immunosuppression, high baseline viral load, longer ART duration, younger age and male gender [8][9][10][11][12][13]. Failure to achieve virological suppression has also been linked to various socio-demographic factors, including unstable housing, low educational status, unemployment and lack of financial or social support [14][15][16][17]. These factors have been associated with disease outcomes in a range of both communicable and non-communicable conditions, and are considered as important determinants of health [18].…”
Introduction
The potential impact of socio-economic condition on virological suppression during antiretroviral treatment (ART) in sub-Saharan Africa is largely unknown. In this case-control study, we compared socio-economic factors among Ethiopian ART recipients with lack of virological suppression to those with undetectable viral load (VL).
Methods
Cases (VL>1000 copies/ml) and controls (VL<150 copies/ml) aged ≥15years, with ART for >6 months and with available VL results within the last 3 months, were identified from registries at public ART clinics in Central Ethiopia. Questionnaire-based interviews on socio-economic characteristics, health condition and transmission risk behavior were conducted. Univariate variables associated with VL>1000 copies/ml (p<0.25) were added to a multivariable logistic regression model.
Results
Among 307 participants (155 cases, 152 controls), 61.2% were female, and the median age was 38 years (IQR 32–46). Median HIV-RNA load among cases was 6,904 copies/ml (IQR 2,843–26,789). Compared to controls, cases were younger (median 36 vs. 39 years; p = 0.004), more likely to be male (46.5% vs. 30.9%; p = 0.005) and had lower pre-ART CD4 cell counts (170 vs. 220 cells/μl; p = 0.009). In multivariable analysis of urban residents (94.8%), VL>1000 copies/ml was associated with lower relative wealth (adjusted odds ratio [aOR] 2.98; 95% CI 1.49–5.94; p = 0.016), geographic work mobility (aOR 6.27, 95% CI 1.82–21.6; p = 0.016), younger age (aOR 0.94 [year], 95% CI 0.91–0.98; p = 0.011), longer duration of ART (aOR 1.19 [year], 95% CI 1.07–1.33; p = 0.020), and suboptimal (aOR 3.83, 95% CI 1.33–10.2; p = 0.048) or poor self-perceived wellbeing (aOR 9.75, 95% CI 2.85–33.4; p = 0.012), after correction for multiple comparisons. High-risk sexual behavior and substance use was not associated with lack of virological suppression.
Conclusion
Geographic work mobility and lower relative wealth were associated with lack of virological suppression among Ethiopian ART recipients in this predominantly urban population. These characteristics indicate increased risk of treatment failure and the need for targeted interventions for persons with these risk factors.
“…Detectable VL was more common among ART recipients in the United Kingdom with unstable housing, non-university education, unemployment and financial hardship [15]. Other social and structural factors, such as homelessness, injection drug use and lack of social support, have also been associated with viremia during ART [16,17].…”
Section: Discussionmentioning
confidence: 99%
“…Lack of virological suppression during ART has been associated with advanced immunosuppression, high baseline viral load, longer ART duration, younger age and male gender [8][9][10][11][12][13]. Failure to achieve virological suppression has also been linked to various socio-demographic factors, including unstable housing, low educational status, unemployment and lack of financial or social support [14][15][16][17]. These factors have been associated with disease outcomes in a range of both communicable and non-communicable conditions, and are considered as important determinants of health [18].…”
Introduction
The potential impact of socio-economic condition on virological suppression during antiretroviral treatment (ART) in sub-Saharan Africa is largely unknown. In this case-control study, we compared socio-economic factors among Ethiopian ART recipients with lack of virological suppression to those with undetectable viral load (VL).
Methods
Cases (VL>1000 copies/ml) and controls (VL<150 copies/ml) aged ≥15years, with ART for >6 months and with available VL results within the last 3 months, were identified from registries at public ART clinics in Central Ethiopia. Questionnaire-based interviews on socio-economic characteristics, health condition and transmission risk behavior were conducted. Univariate variables associated with VL>1000 copies/ml (p<0.25) were added to a multivariable logistic regression model.
Results
Among 307 participants (155 cases, 152 controls), 61.2% were female, and the median age was 38 years (IQR 32–46). Median HIV-RNA load among cases was 6,904 copies/ml (IQR 2,843–26,789). Compared to controls, cases were younger (median 36 vs. 39 years; p = 0.004), more likely to be male (46.5% vs. 30.9%; p = 0.005) and had lower pre-ART CD4 cell counts (170 vs. 220 cells/μl; p = 0.009). In multivariable analysis of urban residents (94.8%), VL>1000 copies/ml was associated with lower relative wealth (adjusted odds ratio [aOR] 2.98; 95% CI 1.49–5.94; p = 0.016), geographic work mobility (aOR 6.27, 95% CI 1.82–21.6; p = 0.016), younger age (aOR 0.94 [year], 95% CI 0.91–0.98; p = 0.011), longer duration of ART (aOR 1.19 [year], 95% CI 1.07–1.33; p = 0.020), and suboptimal (aOR 3.83, 95% CI 1.33–10.2; p = 0.048) or poor self-perceived wellbeing (aOR 9.75, 95% CI 2.85–33.4; p = 0.012), after correction for multiple comparisons. High-risk sexual behavior and substance use was not associated with lack of virological suppression.
Conclusion
Geographic work mobility and lower relative wealth were associated with lack of virological suppression among Ethiopian ART recipients in this predominantly urban population. These characteristics indicate increased risk of treatment failure and the need for targeted interventions for persons with these risk factors.
“…Poverty and deprivation are reported as fundamentally neighbourhood or area level factors and based on contextspecific measurement tools, including the Evaluation of Deprivation and Inequalities in Health Examination Centres (EPICES). Two of nine studies reported a significant adjusted negative association with virological suppression and deprivation [95,115]. For instance, Raho-Moussa et al [115] found that individuals who reported either individual determinants of deprivation (specifically financial difficulties in past month) or had an EPICES score indicating residence in a deprived state were 66% (aOR 0.34; 95% CI 0.16, 0.72) and 65% (aOR 0.35; 95% CI 0.14, 0.85) less likely, respectively, to achieve a VL < 50 copies/mL, compared to people living with HIV who did not meet these measures of deprivation, after adjusting for age and medication-, and clinically-related factors.…”
Section: Poverty and Deprivationmentioning
confidence: 99%
“…Two of nine studies reported a significant adjusted negative association with virological suppression and deprivation [95,115]. For instance, Raho-Moussa et al [115] found that individuals who reported either individual determinants of deprivation (specifically financial difficulties in past month) or had an EPICES score indicating residence in a deprived state were 66% (aOR 0.34; 95% CI 0.16, 0.72) and 65% (aOR 0.35; 95% CI 0.14, 0.85) less likely, respectively, to achieve a VL < 50 copies/mL, compared to people living with HIV who did not meet these measures of deprivation, after adjusting for age and medication-, and clinically-related factors. Only one study reported a significant adjusted association with medication adherence which was in a negative direction [63].…”
Despite developments in HIV treatment and care, disparities persist with some not fully benefiting from improvements in the HIV care continuum. We conducted a systematic review to explore associations between social determinants and HIV treatment outcomes (viral suppression and treatment adherence) in high-income countries. A random effects meta-analysis was performed where there were consistent measurements of exposures. We identified 83 observational studies eligible for inclusion. Social determinants linked to material deprivation were identified as education, employment, food security, housing, income, poverty/deprivation, socioeconomic status/position, and social class; however, their measurement and definition varied across studies. Our review suggests a social gradient of health persists in the HIV care continuum; people living with HIV who reported material deprivation were less likely to be virologically suppressed or adherent to antiretrovirals. Future research should use an ecosocial approach to explore these interactions across the lifecourse to help propose a causal pathway.
“…Migrant people or people with social vulnerability respond less well to ART. 35 A survey analysing the Bichat hospital's HIV care unit database in 2015 showed that transgender people were more exposed to HIV and other sexually transmitted infections (STI) than other populations, and that their dermatological complications needed better management. 36 A second survey in the same care unit, which aimed to highlight the dangers associated with the clandestine use of cosmetic surgery, reinforced these results and showed that transgender women also presented physical health risks related to the illicit use of silicone.…”
Section: Strengths and Limitations Of This Studymentioning
IntroductionTransgender identity is poorly accepted in France, and data on living conditions and the daily difficulties transgender people encounter are scarce. This lack of data reinforces their invisibility in social life, contributes to their stigmatisation and probably increases the burden of HIV infection, especially for HIV-positive transgender people (TRHIV). The main objective of the community-based research study ANRS Trans&HIV is to identify personal and social situations of vulnerability in TRHIV, the obstacles they encounter in terms of access to and retention in medical care, and their gender affirmation and HIV care needs.Methods and analysisANRS Trans&HIV is a national, comprehensive, cross-sectional survey of all TRHIV currently being followed in HIV care units in France. TRHIV women are exclusively included in the quantitative component, and TRHIV men in the qualitative component. Data are collected by community-based interviewers and will be analysed to explore patient care pathways and living conditions in the TRHIV population with regard to gender affirmation and HIV. Data collection began in October 2020 and should be completed in December 2021. The statistical analyses techniques used will be adapted to each of the study’s objectives and to the type of data collected (cross-sectional (questionnaires) and retrospective (biographical trajectory)). The study’s results will provide a greater understanding of TRHIV health needs in order to suggest possible national recommendations for comprehensive HIV and gender affirmation medical care.Ethics and disseminationANRS Trans&HIV was approved by Inserm’s Ethical Evaluation Committee (no 20-694 on 12 May 2020) and is registered with the National Commission on Informatics and Liberty under number 2518030720. Potential participants are informed about the study through an information note provided by their attending HIV physician. All results published in peer-reviewed journals will be disseminated to the HIV transgender community, institutional stakeholders and healthcare providers.Trial registration numberNCT04849767.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.